Friday 11 Jul, 2025 10:17 AM
Site map | Locate Us | Login
   Anand Rathi jumps after Q1 PAT climbs 28% YoY to Rs 94 cr    SPML Infra gains after securing Rs 385 crore jal jeevan mission contract    Enviro Infra edges higher after bagging maiden order in ZLD space from MIDC    Xchanging Solutions Ltd Slides 4.29%, BSE Information Technology index Shed 1.64%    Hindustan Unilever Ltd Surges 2.46%    Kirloskar Electric re-appoints Anand B Hunnur as MD for 3 years    TCS' PAT climbs 4% QoQ to Rs 12,760 cr in Q1 FY26; declares dividend of Rs 11/shr    GP Eco Solutions hits the roof after bagging Rs 121-cr solar order    Krystal Integrated hits the roof on securing Rs 20-cr facility management contract for JPNI airport    Desco Infratech gains on bagging Rs 2-cr of order    JTL Inds jumps on expansion plan    Metropolis Healthcare Ltd leads losers in 'A' group    Eimco Elecon (India) Ltd leads losers in 'B' group    Hero MotoCorp appoints Kausalya Nandakumar as CBO of emerging mobility unit    Jagatjit Industries CEO & CFO Anil Vanjani resigns 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Shilpa Medicare gains on receiving SFDA GMP certification for Bengaluru facility
10-Jul-25   13:23 Hrs IST

The certification follows an on-site inspection conducted from 18 February to 20 February 2025. It was a full GMP inspection of the entire facility, with a specific focus on the Ondansetron Oral Film drug product. Notably, the inspection concluded with zero observations.

Shilpa Medicare's Unit VI is engaged in the manufacturing, testing, storage, and release of finished dosage forms, specifically oral films and transdermal patches. The facility currently supplies oral films to markets including the United States, Australia, and other emerging countries.

In addition to the SFDA certification, the site has also been approved by the European Medicines Agency (EMA), following a recent inspection by Finnish regulators.

Shilpa Medicare is a manufacturer of API, formulation, and development services. Shilpa Medicare (SML) started its operations as an API manufacturer way back in 1987 at Raichur, Karnataka, India.

The company's consolidated net profit fell 40.77% to Rs 14.51 crore, while revenue from operations rose 13.40% to Rs 330.80 crore in Q4 FY25 over Q4 FY24.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | Rights & Obligations-English | (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking | Policy GTC | Policy On Inactive Trading Accounts | Risk Disclosure Hit Count : 42576759
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited